Ostarine (MK-2866)
Active Substance: Ostarine
Description
Ostarine, also known by its developmental code names MK-2866, Enobosarm, GTx-024, and S-22, is a non-steroidal Selective Androgen Receptor Modulator (SARM). SARMs are a class of compounds designed to have similar effects to anabolic steroids, such as promoting muscle and bone growth, but with a more selective action. Unlike traditional steroids, which can have widespread effects on many different tissues, SARMs are intended to primarily target androgen receptors in muscle and bone, while minimizing the impact on other organs. Ostarine was originally developed for the treatment of conditions like muscle wasting (cachexia) in patients with cancer or other chronic illnesses.
Benefits and Side Effects
Benefits:
-
Increased Lean Body Mass: Ostarine has been shown to increase lean body mass, making it popular in the bodybuilding and fitness communities for bulking cycles.
-
Preservation of Muscle Mass: It is also used during cutting cycles to help maintain muscle and strength while in a caloric deficit.
-
Improved Bone Health: Ostarine shows potential for improving bone mineral density, which could be beneficial for conditions like osteoporosis.
-
Reduced Body Fat: Some users report a nutrient partitioning effect, which can lead to enhanced fat loss.
Side Effects:
-
Testosterone Suppression: While often marketed as a "safer" alternative, Ostarine can still suppress the body's natural production of hormones like testosterone. This can lead to hormonal imbalances and related issues.
-
Liver Toxicity: There are reports of drug-induced liver injury (DILI) associated with Ostarine use, with symptoms like jaundice and elevated liver enzymes.
-
Cardiovascular Strain: Ostarine may negatively affect cardiovascular health, with some reported cases of acute myocarditis. It can also alter lipid profiles.
-
Tendon Damage: Some users have experienced tendon ruptures, suggesting a potential negative impact on tendon health.
-
Mood Instability: Hormonal disruption can lead to psychological side effects such as anxiety, irritability, and depression.
-
Unregulated Market: A major risk is that Ostarine is not approved by the FDA for any use and is often sold as a "research chemical." Products can be mislabeled, contaminated, or contain inaccurate dosages, increasing the risk of adverse effects.
Pros and Cons
Pros:
-
Targeted Anabolic Effects: Ostarine is designed to be more selective than traditional anabolic steroids, theoretically leading to fewer side effects on non-skeletal muscle tissue.
-
Oral Administration: It is taken orally, eliminating the need for injections.
-
Potential for Medical Use: Ostarine is still being researched for its therapeutic potential in treating muscle wasting diseases.
Cons:
-
Lack of FDA Approval: The drug is not approved for human consumption, making its long-term safety profile largely unknown.
-
Risk of Contamination: The unregulated market means products can be impure or mislabeled.
-
Hormonal Disruption: Despite its "selective" nature, Ostarine can still suppress natural hormone production, requiring post-cycle therapy (PCT).
-
Possible Serious Side Effects: There is a risk of serious health complications, including liver and cardiovascular issues.
-
Banned by WADA: Ostarine is banned by the World Anti-Doping Agency (WADA) and other sports organizations, meaning athletes who use it risk being disqualified.
Dosage and Frequency
There is no standardized or medically approved dosage for Ostarine. However, based on anecdotal reports and some research, dosages for bodybuilders and athletes typically range from 10 to 30 mg per day. It is often used in cycles of 6 to 8 weeks.
Half-Life and Detection Time
The elimination half-life of Ostarine is approximately 24 hours. This means it takes about 24 hours for the body to metabolize and excrete half of the drug.
The detection time for Ostarine in drug tests can vary, but it is typically detectable in urine for up to 14 to 21 days after the last dose. Detection windows in hair and other biological samples can be much longer.
Sterogenic, Progestronic, and Prolactin Effects
-
Estrogenic Effects: Ostarine is a non-steroidal compound and is not converted to estrogen through aromatization, which is a common process with many anabolic steroids. Therefore, it does not typically cause estrogenic side effects like gynecomastia or water retention.
-
Progestronic Effects: Ostarine does not have progestogenic activity.
-
Prolactin Effects: There is no known evidence to suggest that Ostarine directly affects prolactin levels.
Anabolic Androgenic Ratio
Ostarine is a SARM, and as such, it is designed to be highly anabolic with minimal androgenic effects. The anabolic-to-androgenic ratio is a way to measure a substance's ability to promote muscle growth versus its ability to cause androgenic side effects like prostate enlargement, acne, or male-pattern baldness. While a specific, universally accepted numerical value is not widely available, Ostarine's ratio is considered to be much more favorable (higher in anabolic effects relative to androgenic effects) than traditional anabolic steroids. It is known to have a potent and tissue-selective anabolic activity.
Pharmacological Properties
Half Life
1 days
Active Dose
100%
Detection
5.00 days
Concentration
10 mg/cap
Anabolic/Androgenic Profile
Usage Effectiveness
Activity Profile
Estrogenic
None
Progestanic
None
Water Retention
None
Aromatization
No
Benefits
Dosage Recommendations
Beginner
10-20 mg/week
Intermediate
20-30 mg/week
Advanced
30-40 mg/week
Evidence-based planning resources
Dive deeper into Ostarine (MK-2866) cycle design, stacking options, and harm-reduction checklists available inside Anabolic Planner.
- Ostarine (MK-2866) compound database overviewCompare Ostarine (MK-2866) with other sarm agents in the structured compound index.
- Ostarine (MK-2866) stack and cycle templatesReview evidence-based cycle outlines, dose progressions, and PCT pairings that incorporate Ostarine (MK-2866).
- Harm-reduction guide for Ostarine (MK-2866)Refresh safety monitoring, lab work, and countermeasure strategies tailored for Ostarine (MK-2866) protocols.
Peer-reviewed reference material
Validate mechanisms, contraindications, and regulatory guidance for Ostarine (MK-2866) with trusted clinical databases.
- Ostarine clinical research on PubMedSearch peer-reviewed human and veterinary studies discussing efficacy, endocrine impact, and contraindications.
- Ostarine pharmacology via Drug Information PortalReview mechanisms, synonyms, regulatory status, and toxicology summaries from the U.S. National Library of Medicine.
Side Effects
Common
Severe
Safety Information
Liver Toxicity
Low
Kidney Toxicity
Low
Cardiovascular Risk
Low
Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.